Return On Assets of Intellia Therapeutics, Inc. from 30 Sep 2016 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Intellia Therapeutics, Inc. quarterly and annual Return On Assets in % history and change rate from 30 Sep 2016 to 31 Dec 2025.
  • Intellia Therapeutics, Inc. Return On Assets for the quarter ending 31 Dec 2025 was -45%, a 4.8% decline year-over-year.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2025 was -45%, a 4.8% decline from 2024.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2024 was -43%, a 18% decline from 2023.
  • Intellia Therapeutics, Inc. annual Return On Assets for 2023 was -36%, a 5.6% increase from 2022.
Return On Assets, Quarterly (%)
Return On Assets, YoY Quarterly Change (%)
Return On Assets, Annual (%)
Return On Assets, YoY Annual Change (%)

Intellia Therapeutics, Inc. Quarterly Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
Q4 2025 -45% -2.1% -4.8% 01 Oct 2025 31 Dec 2025
Q3 2025 -45% -2.2% -5.1% 01 Jul 2025 30 Sep 2025
Q2 2025 -45% -4.5% -11% 01 Apr 2025 30 Jun 2025
Q1 2025 -46% -8.4% -22% 01 Jan 2025 31 Mar 2025
Q4 2024 -43% -6.7% -18% 01 Oct 2024 31 Dec 2024
Q3 2024 -42% -8.8% -26% 01 Jul 2024 30 Sep 2024
Q2 2024 -41% -6.8% -20% 01 Apr 2024 30 Jun 2024
Q1 2024 -38% -4.3% -13% 01 Jan 2024 31 Mar 2024
Q4 2023 -36% +2.2% +5.6% 01 Oct 2023 31 Dec 2023
Q3 2023 -34% +4.1% +11% 01 Jul 2023 30 Sep 2023
Q2 2023 -34% -1.5% -4.7% 01 Apr 2023 30 Jun 2023
Q1 2023 -34% -0.82% -2.5% 01 Jan 2023 31 Mar 2023
Q4 2022 -39% -12% -45% 01 Oct 2022 31 Dec 2022
Q3 2022 -38% -11% -40% 01 Jul 2022 30 Sep 2022
Q2 2022 -32% -3.1% -11% 01 Apr 2022 30 Jun 2022
Q1 2022 -33% -7.4% -29% 01 Jan 2022 31 Mar 2022
Q4 2021 -27% +1% +3.6% 01 Oct 2021 31 Dec 2021
Q3 2021 -27% +3.2% +11% 01 Jul 2021 30 Sep 2021
Q2 2021 -29% +1.9% +6.1% 01 Apr 2021 30 Jun 2021
Q1 2021 -25% +7.1% +22% 01 Jan 2021 31 Mar 2021
Q4 2020 -28% +1.2% +4.2% 01 Oct 2020 31 Dec 2020
Q3 2020 -30% -4.1% -16% 01 Jul 2020 30 Sep 2020
Q2 2020 -31% -5.1% -19% 01 Apr 2020 30 Jun 2020
Q1 2020 -32% -7% -28% 01 Jan 2020 31 Mar 2020
Q4 2019 -29% -3.9% -16% 01 Oct 2019 31 Dec 2019
Q3 2019 -26% -0.14% -0.53% 01 Jul 2019 30 Sep 2019
Q2 2019 -26% -1.2% -4.6% 01 Apr 2019 30 Jun 2019
Q1 2019 -25% -1% -4.1% 01 Jan 2019 31 Mar 2019
Q4 2018 -25% -1.9% -8% 01 Oct 2018 31 Dec 2018
Q3 2018 -26% -6% -30% 01 Jul 2018 30 Sep 2018
Q2 2018 -25% -8.9% -55% 01 Apr 2018 30 Jun 2018
Q1 2018 -24% -12% -93% 01 Jan 2018 31 Mar 2018
Q4 2017 -23% -10% -80% 01 Oct 2017 31 Dec 2017
Q3 2017 -20% -6.2% -45% 01 Jul 2017 30 Sep 2017
Q2 2017 -16% 01 Apr 2017 30 Jun 2017
Q1 2017 -13% 01 Jan 2017 31 Mar 2017
Q4 2016 -13% 01 Oct 2016 31 Dec 2016
Q3 2016 -14% 01 Jul 2016 30 Sep 2016

Intellia Therapeutics, Inc. Annual Return On Assets (%)

Period Value YoY Chg Change % Start Date End Date
2025 -45% -2.1% -4.8% 01 Jan 2025 31 Dec 2025
2024 -43% -6.7% -18% 01 Jan 2024 31 Dec 2024
2023 -36% +2.2% +5.6% 01 Jan 2023 31 Dec 2023
2022 -39% -12% -45% 01 Jan 2022 31 Dec 2022
2021 -27% +1% +3.6% 01 Jan 2021 31 Dec 2021
2020 -28% +110% +80% 01 Jan 2020 31 Dec 2020
2019 -138% -113% -452% 01 Jan 2019 31 Dec 2019
2018 -25% -1.9% -8% 01 Jan 2018 31 Dec 2018
2017 -23% -10% -80% 01 Jan 2017 31 Dec 2017
2016 -13% 01 Jan 2016 31 Dec 2016
* An asterisk sign (*) next to the value indicates that the value is likely invalid.